Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma

Study ID: NCT03897543
Start Date: 2019-08-30
End Date: 2023-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

ABX196

Sponsor

Abivax S.A.

Source: clinicaltrials.gov

Share:
Add to list

Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique

Study ID: NCT05045950
Start Date: 2021-11-17
End Date: 2029-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

53

Intervention / Treatment

Memantine -Twice Daily or Extended Release

WBRT utilizing the PRDR technique

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Anti-pneumococcal Vaccine Strategy in Patients with Chronic Lymphocytic Leukemia

Study ID: NCT05417165
Start Date: 2023-09-29
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Pneumococcal 20-valent Conjugate Vaccine

Pneumococcal Polyvalent Vaccine

Sponsor

Seema Bhat

Source: clinicaltrials.gov

Share:
Add to list

Using FAPI PET/MRI to Evaluate Prostate Cancer

Study ID: NCT06675357
Start Date: 2025-08
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

FAPI

Positron Emission Tomography (PET)

Magnetic Resonance Imaging

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial

Study ID: NCT06069726
Start Date: 2024-03-21
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Atezolizumab

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Cognitive Status After Removal of Skull Base Meningioma

Study ID: NCT04635657
Start Date: 2019-12-10
End Date: 2024-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Long-term Cognitive testing

Sponsor

Ohio State University

Source: clinicaltrials.gov

Share:
Add to list

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

Study ID: NCT06533826
Start Date: 2024-10-29
End Date: 2038-08-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

357

Intervention / Treatment

Trastuzumab Deruxtecan

Datopotamab Deruxtecan

Sponsor

Ana C Garrido-Castro, MD

Source: clinicaltrials.gov

Share:
Add to list

AOH1996 for the Treatment of Refractory Solid Tumors

Study ID: NCT05227326
Start Date: 2022-08-12
End Date: 2026-01-29
Study Type

Interventional

Study Phase

Phase1

No. of Participants

92

Intervention / Treatment

PCNA Inhibitor AOH1996

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T

Study ID: NCT06784726
Start Date: 2025-07-15
End Date: 2033-04-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

27

Intervention / Treatment

Odronextamab

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Chimeric Antigen Receptor T-Cell Therapy

Computed Tomography

Leukapheresis

Lumbar Puncture

Positron Emission Tomography

Administration questionnaire

Biopsy

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Addressing Genomic Disparities in Cancer Survivors

Study ID: NCT06073626
Start Date: 2024-07-31
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

428

Intervention / Treatment

Relational agent (RA) / Chatbot

Enhanced Usual Care (EUC)

Sponsor

Rutgers, The State University of New Jersey

Source: clinicaltrials.gov

Share:
Add to list